Industrial Purity Synthesis Route Aromatic Amine Intermediate Production: 2-Fluoro-4-iodoaniline
- [Process Kinetics]: Advanced reduction protocols minimize dehalogenation risks, ensuring >99% assay stability for halogenated substrates.
- [Sourcing Reliability]: Secure tonnage quantities with verified batch-to-batch consistency and factory-direct logistics.
- [Regulatory Alignment]: Full compliance documentation supports REACH and TSCA requirements for scalable commercial viability.
In the landscape of modern pharmaceutical and agrochemical development, the demand for halogenated building blocks continues to escalate. Specifically, 2-Fluoro-4-iodoaniline (CAS: 29632-74-4) serves as a critical precursor for kinase inhibitors, herbicides, and advanced organic materials. However, achieving consistent industrial purity in this aromatic amine intermediate presents distinct synthetic challenges, particularly regarding the stability of the carbon-iodine bond during reduction phases. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. delivers optimized production methodologies that address these technical hurdles while ensuring supply chain security for downstream processors.
Technical Synthesis and Impurity Profile Analysis
For process chemists and R&D teams, the primary objective in producing 1-amino-2-fluoro-4-iodobenzene is the selective reduction of the corresponding nitro precursor without compromising the iodo-substituent. Recent academic literature regarding solid-state photocatalytic hydrogenation indicates that while novel methods achieve high yields for simple nitroarenes, halogenated substrates—particularly those containing iodine—often suffer from inadequate catalytic efficiency or unintended dehalogenation. This underscores the necessity for robust, traditional catalytic hydrogenation or specific chemical reduction routes that prioritize C-I bond retention.
Our synthesis route employs controlled catalytic conditions to mitigate the formation of dehalogenated byproducts, such as 2-fluoroaniline, which can complicate downstream coupling reactions like Suzuki-Miyaura or Buchwald-Hartwig aminations. By maintaining strict parameters on temperature and hydrogen pressure, we achieve a chemical selectivity that exceeds standard market expectations. This level of control is essential for clients requiring a reliable chemical building block for multi-step syntheses where impurity carryover could jeopardize final API registration.
Quality Parameters and Technical Specifications
To facilitate quick evaluation for procurement and quality assurance teams, the following table outlines the standard technical specifications for our commercial-grade inventory. Each batch undergoes rigorous HPLC and GC-MS analysis to verify compliance with these metrics.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 29632-74-4 | N/A |
| Chemical Name | 2-Fluoro-4-iodoaniline (4-iodo-2-fluoroaniline) | N/A |
| Purity (HPLC) | ≥ 99.0% | Area Normalization |
| Dehalogenated Impurities | ≤ 0.5% | GC-MS |
| Appearance | Off-white to Light Yellow Crystal Powder | Visual |
| Moisture Content | ≤ 0.5% | Karl Fischer |
Procurement Strategy and Supply Chain Stability
For procurement managers, securing a stable factory supply is as critical as the chemical specifications themselves. Market volatility can impact the bulk price of raw materials, especially for iodine-containing compounds where elemental iodine costs fluctuate. NINGBO INNO PHARMCHEM CO.,LTD. mitigates this risk through vertical integration and long-term raw material contracts, ensuring that our clients receive consistent pricing and availability regardless of external market pressures.
When sourcing high-purity materials, buyers should prioritize suppliers who offer comprehensive documentation alongside the product. We provide a detailed Certificate of Analysis (COA) with every shipment, verifying the identity and purity of the 2-fluoro-4-iodo aniline or 2-fluoro-4-iodobenzeneamine delivered. This transparency reduces incoming QC workload and accelerates the release of materials into production queues. Our logistics network is optimized for hazardous chemical transport, ensuring safe and timely delivery of tonnage quantities to processing facilities worldwide.
Commercial Viability and Regulatory Compliance
Executive decision-makers must weigh the commercial viability of any intermediate against regulatory hurdles. Utilizing a fluorinated aniline derivative with a validated manufacturing process simplifies the regulatory filing process for downstream pharmaceuticals. Our production facilities adhere to strict environmental and safety standards, aligning with international compliance frameworks such as REACH and TSCA. This commitment reduces the regulatory burden on our partners, allowing them to focus on drug development and market expansion rather than supply chain auditing.
Scalability is another cornerstone of our value proposition. Whether your project requires kilogram-scale samples for clinical trials or metric ton volumes for commercial manufacturing, our infrastructure is designed to scale without compromising the industrial purity established during process development. This flexibility supports the entire product lifecycle, from early-stage discovery to full-scale commercialization.
Conclusion and Technical Support
The production of 2-Fluoro-4-iodoaniline requires a delicate balance of chemical precision and supply chain robustness. By choosing a partner with deep technical expertise in halogenated aromatic reduction, you secure both the quality of your intermediate and the stability of your production schedule. We invite you to contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote to discuss how our capabilities align with your project requirements.